Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohr, D. C.
Right arrow Articles by Goldberg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohr, D. C.
Right arrow Articles by Goldberg, A.
Related Collections
Right arrow Neurology
Right arrow Depression
Right arrow Therapeutic Interventions
Psychosomatic Medicine 65:542-547 (2003)
© 2003 American Psychosomatic Society


ORIGINAL ARTICLES

Effects of Treatment for Depression on Fatigue in Multiple Sclerosis

David C. Mohr, PhD, Stacey L. Hart, PhD and Alison Goldberg, BA

From University of California, San Francisco, Veterans Affairs Medical Center, San Francisco, California.

Address reprint requests to: David C. Mohr, PhD, Veterans Administration Medical Center, 4150 Clement St. (116-A) San Francisco, CA 94121. Email: dmohr{at}itsa.ucsf.edu

Received for publication March 1, 2002; revision received October 29, 2002.

OBJECTIVE: There has long been a belief that depression contributes to fatigue in multiple sclerosis (MS) although supporting data are minimal at best. Clinical guidelines for the treatment of fatigue include recommendations for the treatment of depression in the absence of clear empirical support. The goal of this study was to examine the effects of treatment for depression on fatigue in MS.

METHODS: Sixty patients with a relapsing form of MS and moderate to severe depression were randomly assigned to one of three validated 16-week treatments for depression: individual cognitive behavioral therapy, group psychotherapy, or sertraline. Assessments at baseline and treatment cessation included the primary outcome measure, fatigue assessment instrument (FAI), and Beck depression inventory (BDI).

RESULTS: The total FAI and the global fatigue severity subscale were significantly reduced over the course of treatment (p values <.02). Other subscales did not change significantly. Secondary analyses showed change in global fatigue severity was associated with change in BDI (p = .03) but change in total FAI was only marginally related to change in BDI (p = .05). These relationships were due entirely to change in mood (p values <.02) and not to change in cognitive or vegetative symptoms (p values >.17).

CONCLUSIONS: These findings suggest that treatment for depression is associated with reductions in the severity of fatigue symptoms, and that this relationship is due primarily to treatment related changes in mood.

Key Words: multiple sclerosis, • depression, • fatigue, • treatment, • psychotherapy.

Abbreviations: AI = ambulation index;; BDI = Beck depression inventory;; CBT = cognitive behavior therapy;; FAI = fatigue assessment instrument;; HMRA = hierarchical multiple regression analysis;; MS = multiple sclerosis;; SEGP = supportive-expressive group;; psychotherapy.




This article has been cited by other articles:


Home page
PsychosomaticsHome page
L. M. Arnold
Understanding Fatigue in Major Depressive Disorder and Other Medical Disorders
Psychosomatics, May 1, 2008; 49(3): 185 - 190.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
D. Kos, E. Kerckhofs, G. Nagels, M.B. D'hooghe, and S. Ilsbroukx
Origin of Fatigue in Multiple Sclerosis: Review of the Literature
Neurorehabil Neural Repair, February 1, 2008; 22(1): 91 - 100.
[Abstract] [PDF]


Home page
Mult SclerHome page
J. Benito-Leon, P. Martinez-Martin, B. Frades, M.L. Martinez-Gines, C. de Andres, J.E. Meca-Lallana, A.R. Antiguedad, B. Huete-Anton, E. Rodriguez-Garcia, and J. Ruiz-Martinez
Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS)
Multiple Sclerosis, June 1, 2007; 13(5): 645 - 651.
[Abstract] [PDF]


Home page
Mult SclerHome page
D C Mohr, S L Hart, L Julian, and E S Tasch
Screening for depression among patients with multiple sclerosis: two questions may be enough
Multiple Sclerosis, March 1, 2007; 13(2): 215 - 219.
[Abstract] [PDF]


Home page
Mult SclerHome page
L Julian, N M Merluzzi, and D C Mohr
The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis
Multiple Sclerosis, January 1, 2007; 13(1): 81 - 86.
[Abstract] [PDF]


Home page
Mult SclerHome page
D C Mohr, S L Hart, I Fonareva, and E S Tasch
Treatment of depression for patients with multiple sclerosis in neurology clinics
Multiple Sclerosis, April 1, 2006; 12(2): 204 - 208.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R J Siegert and D A Abernethy
Depression in multiple sclerosis: a review
J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 469 - 475.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
Other articles noted: 25 Jul 03 to 7 Nov 03
Evid. Based Nurs., January 1, 2004; 7(1): e1 - 1.
[Full Text] [PDF]


Home page
JWatch NeurologyHome page
Treatment for Depression Helps Fatigue in Multiple Sclerosis
Journal Watch Neurology, November 7, 2003; 2003(1107): 12 - 12.
[Full Text]


Home page
JWatch PsychiatryHome page
Treatment for Depression Helps Fatigue in Multiple Sclerosis
Journal Watch Psychiatry, October 8, 2003; 2003(1008): 2 - 2.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Psychosomatic Society